ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N07BC51 | G | Buprenorphine HCl - 16mg, Naloxone HCl - 4mg | 9699/945 | 179418/1 | SUBOXONE | 28 | Tablet, sublingual | Oral | Minapharm Halabi | Reckitt Benckiser Healthcare (UK) Ltd | UK | 14,284,125 L.L | 19.35 | D | Indivior (UK) Ltd | UK | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N07BC51 | G | Buprenorphine HCl - 16mg, Naloxone HCl - 4mg | 9699 | 179418/1 | SUBOXONE | 28 | Tablet, sublingual | Oral | Minapharm Halabi | Reckitt Benckiser Healthcare (UK) Ltd | UK | 5,961,029 L.L | 19.35 | D | Indivior (UK) Ltd | UK | 2/5/2024 | 70 |